1h69: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1h69.gif|left|200px]] | [[Image:1h69.gif|left|200px]] | ||
'''CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3,5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM RESOLUTION''' | {{Structure | ||
|PDB= 1h69 |SIZE=350|CAPTION= <scene name='initialview01'>1h69</scene>, resolution 1.86Å | |||
|SITE= <scene name='pdbsite=AC1:Fad+Binding+Site+For+Chain+A'>AC1</scene>, <scene name='pdbsite=AC2:Fad+Binding+Site+For+Chain+B'>AC2</scene>, <scene name='pdbsite=AC3:Fad+Binding+Site+For+Chain+C'>AC3</scene>, <scene name='pdbsite=AC4:Fad+Binding+Site+For+Chain+D'>AC4</scene>, <scene name='pdbsite=AC5:Arh+Binding+Site+For+Chain+A'>AC5</scene>, <scene name='pdbsite=AC6:Arh+Binding+Site+For+Chain+B'>AC6</scene>, <scene name='pdbsite=AC7:Arh+Binding+Site+For+Chain+C'>AC7</scene> and <scene name='pdbsite=AC8:Arh+Binding+Site+For+Chain+D'>AC8</scene> | |||
|LIGAND= <scene name='pdbligand=FAD:FLAVIN-ADENINE+DINUCLEOTIDE'>FAD</scene> and <scene name='pdbligand=ARH:3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE'>ARH</scene> | |||
|ACTIVITY= [http://en.wikipedia.org/wiki/Transferred_entry:_1.6.5.2 Transferred entry: 1.6.5.2], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.6.99.2 1.6.99.2] | |||
|GENE= | |||
}} | |||
'''CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3,5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM RESOLUTION''' | |||
==Overview== | ==Overview== | ||
Line 10: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
1H69 is a [ | 1H69 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1H69 OCA]. | ||
==Reference== | ==Reference== | ||
Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones., Faig M, Bianchet MA, Winski S, Hargreaves R, Moody CJ, Hudnott AR, Ross D, Amzel LM, Structure. 2001 Aug;9(8):659-67. PMID:[http:// | Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones., Faig M, Bianchet MA, Winski S, Hargreaves R, Moody CJ, Hudnott AR, Ross D, Amzel LM, Structure. 2001 Aug;9(8):659-67. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11587640 11587640] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
Line 29: | Line 38: | ||
[[Category: rossman fold]] | [[Category: rossman fold]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 11:32:48 2008'' |